Background illustration for clinical trials search

Paid Clinical Trials Hialeah

Discover 1,934 paid clinical trials in Hialeah, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Use of CereGate Therapy for Freezing of Gait in PD

for
Parkinson Disease, Freezing of Gait, Deep Brain Stimulation
Location: Miami FL, Winston-Salem NC, Nashville TN, Chicago IL,
Sponsor: CereGate Inc.

Sex: All

Age: 21 - 70+

Code: NCT05292794

Recruiting

Rib Fixation for Clinically Severe Rib Fractures From Trauma

for
Rib Fracture, Flail Chest
Location: Miami FL, Fort Pierce FL, Sanford FL, Ocala FL,
Sponsor: Darwin Ang

Sex: All

Age: 18 - 70+

Code: NCT02595593

Recruiting

This Trial is a Clinical Performance Validation Study That Will Evaluate the Clinical Agreement of the Sky Medical™ Rapid Antigen Test Comparing the Antigen Rapid Test to RT-PCR

for
COVID-19, Sars-CoV-2 Infection
Location: Lake Worth FL
Sponsor: Sky Medical Supplies & Equipments, LLC

Sex: All

Age: 7+

Code: NCT05491993

Recruiting

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

for
Type 1 Diabetes Mellitus
Location: Miami FL
Sponsor: Rodolfo Alejandro

Sex: All

Age: 18 - 70

Code: NCT01999361

Recruiting

Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study

for
Clonal Cytopenia of Undetermined Significance
Location: Miami FL, Nashville TN, Columbus OH, New York NY,
Sponsor: Uma Borate

Sex: All

Age: 18+

Code: NCT05641831

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

for
Chronic Lymphocytic Leukemia (CLL),
Location: Miami FL, Sarasota FL, Atlanta GA, Durham NC,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05131022

Phase 1, Recruiting

SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

for
Neuroendocrine Carcinoma, Neuroendocrine Tumors
Location: Miami FL
Sponsor: Peter Hosein, MD

Sex: All

Age: 18+

Code: NCT06889493

Phase 1, Recruiting

CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).

for
Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma,
Location: Miami FL
Sponsor: Lazaros Lekakis

Sex: All

Age: 18 - 70+

Code: NCT05260957

Phase 2, Recruiting

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Miami FL, Atlanta GA, Birmingham AL, Nashville TN,
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT05911568

Recruiting

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

for
Open tíbia Fracture
Location: Miami FL, Gainesville FL, Jacksonville FL, Columbia SC,
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT05615844

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

for
Persistent Corneal Epithelial Defect
Location: South Miami FL, Fort Myers FL, Bradenton FL, Dothan AL,
Sponsor: Glaukos Corporation

Sex: All

Age: 2+

Code: NCT05966493

Phase 2, Recruiting

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

for
Leukemia, Juvenile Myelomonocytic, JMML, JCML,
Location: Miami FL, Atlanta GA, Charlotte NC, Memphis TN,
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All

Age: 0 - 21

Code: NCT05849662

Phase 1, Phase 2, Recruiting

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Fort Lauderdale FL, Charleston SC, Gulfport MS,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT04566328

Phase 3, Recruiting

Comprehensive Behavioral Intervention for Tics

for
Tic Disorders
Location: Coral Gables FL
Sponsor: University of Miami

Sex: All

Age: 5 - 17

Code: NCT05370391

Recruiting

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

for
Cardiotoxicity, HER2/Neu Positive,
Location: Weston FL, Tampa FL, Thomasville GA, Savannah GA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT03418961

Phase 3, Recruiting

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

for
Glioblastoma, Gliosarcoma
Location: Miami FL, Indianapolis IN, Middletown NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06934889

Phase 1, Recruiting

The Less is More Study

for
Alcohol Use
Location: Coral Gables FL, Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 35 - 70

Code: NCT05153811

Recruiting

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Coral Gables FL, Charlotte NC, Nashville TN, Fairfax VA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05118789

Phase 1, Phase 2, Recruiting

Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.

for
Nephrolithiasis, Urosepsis
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT04669886

Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Pembroke Pines FL, Miami FL, Albany GA, Seneca SC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase 2, Recruiting